about
microRNA regulation of peritoneal cavity homeostasis in peritoneal dialysisOmics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric DisordersNew frontiers in obstructive sleep apnoeaBiomarker validation: common data analysis concernsTranslational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug DiscoveryFortune telling: metabolic markers of plant performanceInformatic system for a global tissue-fluid biorepository with a graph theory-oriented graphical user interfaceThe use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholdersPositing, fitting, and selecting regression models for pooled biomarker data.Identifying network-based biomarkers of complex diseases from high-throughput data.Exosomal miRNAs as potential biomarkers of cardiovascular risk in children.Recombinant TSH stimulated remnant ablation therapy in thyroid cancer: the success rate depends on the definition of ablation success--an observational study.Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.Translational biomarkers of acetaminophen-induced acute liver injuryResearch priorities in biomarkers and surrogate end-points.Monitoring for adverse drug reactions.Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations.The prognostic value of the serum ferritin in a southern Brazilian cohort of patients with Gaucher diseaseAdvancing outcome measures for the new era of drug development in cystic fibrosis.Clinical pharmacology--providing tools and expertise for translational medicineBiomarker discovery in animal health and disease: the application of post-genomic technologies.Alzheimer's disease drug development: old problems require new priorities.A preliminary study of movement intensity during a Go/No-Go task and its association with ADHD outcomes and symptom severity.Circulating Biomarkers for Duchenne Muscular Dystrophy.Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.Medication use evaluation: pharmacist rubric for performance improvement.Chronic stress impacts the cardiovascular system: animal models and clinical outcomes.Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians.Salivary Biomarkers of Chronic Psychosocial Stress and CVD Risks: A Systematic Review.Biomarkers in traumatic brain injury: a review.Brain-Specific Serum Biomarkers Predict Neurological Morbidity in Diagnostically Diverse Pediatric Intensive Care Unit Patients.A brief review and evaluation of earthworm biomarkers in soil pollution assessment.MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice.Biomarkers of skin aging.Alternative designs for clinical trials in rare diseases.Biomarkers-A General Review.STANDARDIZED OUTCOMES IN NEPHROLOGY-PERITONEAL DIALYSIS (SONG-PD): STUDY PROTOCOL FOR ESTABLISHING A CORE OUTCOME SET IN PD.A Review of Biomarkers for Neurodegenerative Disease: Will They Swing Us Across the Valley?Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies.Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed.
P2860
Q26779972-DCE71BF5-E612-4BEB-8875-211468F08D79Q26784904-21A76F85-0F3B-41D1-ACCA-63CB1B7C3881Q26823972-3BBEF831-3D30-4B6B-B5F5-F2C3F3069DA3Q27024057-5C42B768-B01C-46E7-9BF4-F297980302DDQ28072402-BEBAADD0-95BE-4AA6-A9FC-23FEE03ECD00Q28075460-6274B8E7-B05F-4D8E-8126-AADE8E824E18Q28394723-47EA3F52-33DE-4879-9D1D-0493F224FB8BQ28543430-F2B9177A-31B9-4FC2-BFA9-C0A2B254EFF0Q30924755-E99AF5B0-8A29-4EAD-8409-20F7CF59C033Q31038202-5C112F21-5AF4-43F4-8C4C-41DF8DAF8E70Q33756578-E6260094-6B54-4506-B296-4FA2DCF64D03Q35201397-A21C1239-172F-4865-A006-86045E15BD6AQ35319254-7DE24BF5-DD6A-4CD6-927A-8670B2D2F0B6Q36001451-A75DDB17-4A92-4682-9815-FABA04C2B44BQ36081463-8FB1AB62-3B64-4F09-8C1D-A57C46E829B7Q36423153-EBC31306-EEB4-4BC0-ADBD-CB8A663D4E8BQ36677856-1B76C7DB-7FA1-4A8F-B5DB-E170405BE316Q36727748-81EC625C-3F6F-489C-9414-EC5A6CBC4036Q36891530-53AD6285-A082-4FFF-8507-545C4AA5AF56Q37077687-95140FF3-F6EF-4C99-83E3-BEC695B17E11Q37280937-A1911997-ED83-4105-8C95-FD390D38800CQ37363992-844D133D-9560-48FA-829E-7E32131B8F8EQ37498088-9F10A107-27A4-4503-9D52-1E23910AE610Q37610530-0A17C2DC-43EA-4E84-8354-D3E2BB34AFEBQ38222874-A11A3BBA-3CBB-497C-927F-191D94339316Q38293085-F2501F11-7B8A-4D05-B174-3BA81D46C0D0Q38427411-CC4D8550-136A-41D2-898A-88C367BF8937Q38434908-94CFA524-1DEB-4829-9B75-380CDBFA2094Q38582967-9D11681C-CDEC-40D5-9306-569A8EECBD7AQ38623128-6A23C2F5-91A1-4AF1-97B9-57FA32D27342Q38726719-9C618837-9B01-4EE7-B702-63107AE927EDQ38734331-612BABE8-5E56-4CF5-8687-2C6D3ED2FC3CQ38867829-CD80FC81-F9C4-4A7A-AB3F-DCDF78A3C89CQ39004240-656D780C-74B2-4D5E-93C9-ED80B3FF6E43Q39013156-E17439D7-D6E1-4267-AD65-91CF08FFD30BQ39183771-5770FD9E-55E6-434D-ACC5-47F173C3EF6DQ39210349-3673AD18-2364-4E27-94FF-927FE3E85F45Q39451637-B3D51170-A621-48D2-B9CA-277F15A7ADAFQ42363358-41BA3A60-0FF2-4F41-9981-275D90A292DDQ42758802-D7E6619B-E8BB-4EB4-AB79-6FEF8E5BA779
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Biomarkers and surrogate endpoints
@ast
Biomarkers and surrogate endpoints
@en
Biomarkers and surrogate endpoints
@nl
type
label
Biomarkers and surrogate endpoints
@ast
Biomarkers and surrogate endpoints
@en
Biomarkers and surrogate endpoints
@nl
prefLabel
Biomarkers and surrogate endpoints
@ast
Biomarkers and surrogate endpoints
@en
Biomarkers and surrogate endpoints
@nl
P2860
P3181
P1476
Biomarkers and surrogate endpoints
@en
P2093
J K Aronson
P2860
P3181
P356
10.1111/J.1365-2125.2005.02435.X
P407
P577
2005-05-01T00:00:00Z